ATE293978T1 - Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung - Google Patents

Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung

Info

Publication number: ATE293978T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; treatment method; emergency contraception; contraception; emergency
Prior art date: 2001-11-27

Application number

AT02783334T

Other languages

English (en)

Inventor

Look Paul F A Van

Illesne Balogh

Katalin Komandi

Laszlo Nemes

Zsolt Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2002-11-26

Publication date

2005-05-15

2002-11-26 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE293978T1 publication Critical patent/ATE293978T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

AT02783334T 2001-11-27 2002-11-26 Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung ATE293978T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en)	2001-11-27	2002-11-26	Dosage regimen and pharmaceutical composition for emergency contraception

Publications (1)

Publication Number	Publication Date
ATE293978T1 true ATE293978T1 (de)	2005-05-15

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02783334T ATE293978T1 (de)	2001-11-27	2002-11-26	Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung

Country Status (33)

Country	Link
US (1)	US20050288264A2 (de)
EP (1)	EP1448207B1 (de)
JP (1)	JP2005516904A (de)
KR (1)	KR100908161B1 (de)
CN (1)	CN1551774A (de)
AP (1)	AP1849A (de)
AT (1)	ATE293978T1 (de)
AU (1)	AU2002347401A1 (de)
BR (1)	BR0210595A (de)
CA (1)	CA2450359C (de)
DE (1)	DE60203929T2 (de)
DK (1)	DK1448207T3 (de)
EA (1)	EA006545B1 (de)
EC (1)	ECSP045171A (de)
ES (1)	ES2239727T3 (de)
GE (1)	GEP20063882B (de)
HR (1)	HRP20040584B1 (de)
HU (1)	HU227198B1 (de)
IL (1)	IL159394A0 (de)
IS (1)	IS2691B (de)
MA (1)	MA27076A1 (de)
MX (1)	MXPA04005104A (de)
NO (1)	NO333984B1 (de)
NZ (1)	NZ530056A (de)
OA (1)	OA12730A (de)
PL (1)	PL206010B1 (de)
PT (1)	PT1448207E (de)
RS (1)	RS50768B (de)
SI (1)	SI1448207T1 (de)
TN (1)	TNSN04048A1 (de)
UA (1)	UA79942C2 (de)
WO (1)	WO2003045397A1 (de)
ZA (1)	ZA200404114B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2674776A1 (en) *	2006-12-20	2008-07-03	Duramed Pharmaceuticals, Inc.	Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EA201070715A1 (ru) *	2007-12-20	2011-02-28	Тева Вимен'С Хелс, Инк.	Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
EP2365811A1 (de) *	2008-12-12	2011-09-21	Laboratoire HRA Pharma	Empfängnisverhütungsverfahren
HRP20161437T1 (hr)	2009-04-14	2017-02-10	Laboratoire Hra Pharma	Postupak hitne kontracepcije
NZ597239A (en) *	2009-06-23	2013-07-26	Bayer Pharma AG	Pharmaceutical composition for emergency contraception
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
AU2012264601C1 (en)	2011-06-01	2018-01-25	Estetra Srl	Process for the production of estetrol intermediates
PT2714710T (pt)	2011-06-01	2016-07-12	Estetra Sprl	Processo para a produção de intermediários de estetrol
EP2383279A1 (de)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Herstellungsverfahren für Esterol
HRP20170797T1 (hr) *	2011-08-11	2017-08-11	Estetra S.P.R.L.	Primjena estetrola kao hitnog kontraceptiva
WO2014079840A1 (de)	2012-11-22	2014-05-30	Bayer Pharma Aktiengesellschaft	Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption
TN2015000511A1 (en)	2013-05-23	2017-04-06	Bayer Pharma AG	Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
MY195019A (en)	2015-06-18	2023-01-03	Estetra Sprl	Orodispersible dosage unit containing an estetrol component
JP6866560B2 (ja)	2015-06-18	2021-04-28	エステトラソシエテプリーヴアレスポンサビリテリミテ	エステトロール成分を含有する口腔内崩壊性投与単位
MD3310346T2 (ro)	2015-06-18	2021-06-30	Estetra Sprl	Comprimată orodispersabilă ce conține estetrol
HUE054589T2 (hu)	2015-06-18	2021-09-28	Estetra Sprl	Szájban diszpergálódó esztetrol tartalmú tabletta
KR102712911B1 (ko)	2016-08-05	2024-10-04	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	월경통 및 생리통의 관리방법
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
WO2022026901A2 (en) *	2020-07-30	2022-02-03	Acer Therapeutics Inc.	Nk antagonists for contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/de not_active Expired - Lifetime
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en not_active Ceased
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
IS2691B (is)	2010-10-15
PL369520A1 (en)	2005-04-18
CA2450359C (en)	2011-05-10
US20050288264A2 (en)	2005-12-29
GEP20063882B (en)	2006-07-25
RS4204A (sr)	2007-02-05
PT1448207E (pt)	2005-08-31
AP2004003046A0 (en)	2004-06-30
CN1551774A (zh)	2004-12-01
RS50768B (sr)	2010-08-31
MA27076A1 (fr)	2004-12-20
MXPA04005104A (es)	2004-08-19
IL159394A0 (en)	2004-06-01
IS7065A (is)	2003-12-05
HU227198B1 (en)	2010-10-28
JP2005516904A (ja)	2005-06-09
HUP0105173D0 (en)	2002-02-28
SI1448207T1 (en)	2005-10-31
PL206010B1 (pl)	2010-06-30
AU2002347401A1 (en)	2003-06-10
HRP20040584A2 (en)	2005-02-28
DE60203929D1 (de)	2005-06-02
TNSN04048A1 (en)	2006-06-01
HUP0105173A2 (hu)	2003-08-28
KR20040066088A (ko)	2004-07-23
BR0210595A (pt)	2004-06-08
ECSP045171A (es)	2004-08-27
EA200400731A1 (ru)	2004-12-30
DE60203929T2 (de)	2006-01-19
NZ530056A (en)	2005-02-25
US20050032755A1 (en)	2005-02-10
KR100908161B1 (ko)	2009-07-16
ZA200404114B (en)	2005-10-26
NO333984B1 (no)	2013-11-04
UA79942C2 (en)	2007-08-10
EA006545B1 (ru)	2006-02-24
WO2003045397A1 (en)	2003-06-05
EP1448207B1 (de)	2005-04-27
DK1448207T3 (da)	2005-06-27
ES2239727T3 (es)	2005-10-01
HUP0105173A3 (en)	2004-03-29
CA2450359A1 (en)	2003-06-05
OA12730A (fr)	2006-06-28
AP1849A (en)	2008-05-23
HRP20040584B1 (en)	2012-11-30
EP1448207A1 (de)	2004-08-25
NO20041607L (no)	2004-04-20

Publication	Publication Date	Title
ATE293978T1 (de)	2005-05-15	Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung
ATA1292000A (de)	2001-10-15	Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
DE60121992D1 (de)	2006-09-14	Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
GB2402063B (en)	2007-02-28	Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
HU0103558D0 (en)	2001-11-28	Pharmaceutical composition for the treatment of stroke and traumatic brain insury
DE50206657D1 (de)	2006-06-08	Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60239648D1 (de)	2011-05-12	Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
AUPR638101A0 (en)	2001-08-09	Composition and method for treatment of disease
DE60041782D1 (de)	2009-04-23	Bioaktiver und osteoporotischer knochenzement
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
ATE456954T1 (de)	2010-02-15	Pharmazeutische zusammenstellung zur verwendung in notbehandlungen und dessen herstellungsverfahren
BRPI0209720A2 (pt)	2017-06-13	dosagem e embalagem de medicação com liberação controlada
FI20011403L (fi)	2002-12-30	Menetelmä ja koostumukset vatsan sairauksien hoitoon
PL362920A1 (en)	2004-11-02	Therapeutic film forming composition and treatment system
DE60218375D1 (de)	2007-04-12	Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
IS7266A (is)	2004-05-14	Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60016047D1 (de)	2004-12-23	Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60329614D1 (de)	2009-11-19	Polymerzusammensetzung sowie diese enthaltende darreichungsformen
IL173148A0 (en)	2006-06-11	Methods and pharmaceutical compositions for healing wounds
AU2002325169A1 (en)	2003-03-03	Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
HUP0103017A3 (en)	2004-05-28	Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
BR0212383B1 (pt)	2013-10-08	Composição de condicionamento de tecido e método para o tratamento de tecidos
HUP0203676A3 (en)	2003-08-28	Pharmaceutical composition and method for treatment of diabetes
ATE302183T1 (de)	2005-09-15	Indenoindolin derivate, verfahren zur herstellung dieser derivate und diese enthaltende pharmazeutische präparate
ATE355823T1 (de)	2007-03-15	Pharmazeutische zusammensetzung für die nasale verabreichung von östradiol und norethisteron

Legal Events

Date	Code	Title	Description
2005-11-15	UEP	Publication of translation of european patent specification	Ref document number: 1448207 Country of ref document: EP

Date

Code

Title

Description

2005-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1448207

Country of ref document: EP